Marker Therapeutics
MRKR
MRKR
63 hedge funds and large institutions have $44.7M invested in Marker Therapeutics in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 25 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
52% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 25
67% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 15
Holders
63
Holding in Top 10
–
Calls
$749K
Puts
$247K
Top Buyers
| 1 | +$989K | |
| 2 | +$979K | |
| 3 | +$307K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$215K |
| 5 |
MLIC
Mandatum Life Insurance Company
Helsinki,
Finland
|
+$167K |
Top Sellers
| 1 | -$1.09M | |
| 2 | -$805K | |
| 3 | -$453K | |
| 4 |
E
Ergoteles
New York
|
-$383K |
| 5 |
D.E. Shaw & Co
New York
|
-$296K |